Skip to main content
Generix Group S.A. logo

Generix Group S.A. — Investor Relations & Filings

Ticker · GENX ISIN · FR0010501692 LEI · 9695003QNWHLC60H9E89 PA Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 466 across all filing types
Latest filing 2018-11-27 Earnings Release
Country FR France
Listing PA GENX

About Generix Group S.A.

https://www.generixgroup.com/en

Generix Group is a global SaaS company that provides a portfolio of AI-powered, cloud-based solutions to streamline mission-critical digital processes in supply chain, finance, and commerce. The company's software suite is designed to help businesses build collaborative digital networks with their trading partners. Key offerings include Warehouse Management Systems (WMS), Transportation Management, B2B Integration, and automated invoice management. By digitizing the flow of goods and data, Generix Group enables organizations to optimize operations, enhance productivity, and manage end-to-end processes from procurement to payment and from order to delivery.

Recent filings

Filing Released Lang Actions
GENERIX-GROUP-EN-FINA-PR-RST-S1-2018-2019
Earnings Release Classification · 99% confidence The document is explicitly titled "FINANCIAL PRESS RELEASE" and details the company's results for the "Six months ended September 30, 2018." It presents key financial metrics (Revenues, EBITDA, Operating income, Net profit) and confirms future guidance. This structure is characteristic of an Earnings Release (ER) or an Interim/Quarterly Report (IR). Since it provides comprehensive financial tables and detailed commentary on the half-year performance, it aligns best with the definition of an Interim / Quarterly Report (IR). However, the document starts as a 'Financial Press Release' announcing the results, which often overlaps with an Earnings Release (ER). Given the depth of the financial tables (including full cash flow and balance sheet elements), it leans towards a comprehensive report rather than just the initial highlights (ER). The period covered is a half-year, making 'IR' (Interim / Quarterly Report) the most precise fit among the comprehensive report types, as '10-K' is annual. The document also mentions the 'Half-Year Financial Report' is available elsewhere, suggesting this press release serves as the primary announcement of those results. H1 2019
2018-11-27 English
Generix-Group-CP-droits-vote-actions-31-10-2018
Share Issue/Capital Change Classification · 95% confidence The document is titled "COMMUNIQUE FINANCIER" and explicitly states it provides "Information relative au nombre total de droits de vote et d'actions" (Information relative to the total number of voting rights and shares). It cites French regulatory articles (Code de Commerce and AMF general regulation) requiring disclosure of the total number of shares and voting rights, typically published monthly. This specific disclosure relates to the total share count and voting rights as of a specific date (31/10/2018). This type of mandatory periodic disclosure regarding share capital structure and voting rights is best classified under Share Issue/Capital Change (SHA) or potentially a general Regulatory Filing (RNS). Given the specific focus on the total number of shares and voting rights, SHA is the most precise fit, as it deals directly with the capital structure components.
2018-11-13 French
EXT-FR-FINA-CP-100-Generix-Noram-6-11-2018
M&A Activity Classification · 99% confidence The document is titled "COMMUNIQUE FINANCIER" and announces a specific corporate action: Generix Group acquiring the remaining 30% stake in Generix Group North America to reach 100% ownership. This is a material event related to corporate structure and financing/investment activity. It is not a standard periodic report (10-K, IR, ER) or a general regulatory filing (RNS). It specifically details a transaction involving capital structure/ownership change, fitting best under Capital/Financing Update (CAP) or potentially M&A Activity (TAR). Since it is the acquisition of minority interests leading to full control, it is fundamentally a capital structure change/financing event for the parent company. The document also mentions the upcoming publication of semi-annual results, but the primary focus and headline concern the acquisition. Therefore, CAP is the most appropriate classification.
2018-11-06 French
EXT-FR-FINA-CP-Emission-BSA-5-11-2018
Share Issue/Capital Change Classification · 99% confidence The document is titled "COMMUNIQUE FINANCIER" and details the "Emission de Bons de Souscription d'Actions réservée" (Issuance of Stock Warrants reserved for management). This involves the issuance of warrants (BSA) to directors, specifying subscription prices, exercise prices, and capital increase implications. This activity directly relates to changes in the company's capital structure and financing arrangements, specifically through the issuance of equity-linked instruments to insiders. This aligns best with the 'Capital/Financing Update' category (CAP). Although it involves management, the core subject is the financing instrument itself, not just management changes (MANG) or insider trading reports (DIRS). The document is a formal announcement of a capital-related transaction.
2018-11-05 French
Generix Group - droits vote actions - 30 04 2018
Share Issue/Capital Change Classification · 95% confidence The document is titled "COMMUNIQUE FINANCIER" and explicitly states it provides "Information relative au nombre total de droits de vote et d'actions" (Information relative to the total number of voting rights and shares). It cites French regulatory articles (Code de Commerce and AMF general regulation) requiring disclosure of the total number of shares and theoretical voting rights as of a specific date (30/04/2018). This type of mandatory disclosure regarding the total share capital and voting rights is typically classified as a notification related to capital structure or a general regulatory filing. Given the specific nature of reporting the total number of shares and voting rights, it aligns best with a notification concerning share capital changes or a general regulatory update. Since there is no specific code for 'Total Voting Rights Disclosure', and it is a mandatory regulatory disclosure concerning the share base, it fits best under 'Share Issue/Capital Change' (SHA) or as a general 'Regulatory Filing' (RNS). Because it details the current count of shares and voting rights, which is fundamental to capital structure, SHA is a strong candidate. However, the most precise fit among the provided options for a routine disclosure of the total number of shares and voting rights, often published monthly, is often categorized under general regulatory announcements if not explicitly covered elsewhere. Given the options, and recognizing this is a mandatory disclosure about the share base, SHA (Share Issue/Capital Change) is plausible, but RNS (Regulatory Filings) is the safest fallback for mandatory, non-periodic financial reports. Let's re-evaluate the options. This is not a dividend (DIV), not a director dealing (DIRS), not a major shareholding change (MRQ), but a statement of the total outstanding shares. This is most closely related to capital structure changes, even if it's just a periodic update. If we look at the definitions, SHA covers 'new share issues, stock splits, or other capital changes'. A periodic update of the total share count is a direct consequence of capital structure. However, in many databases, this specific type of filing (total voting rights) is often grouped under general regulatory announcements (RNS) when not explicitly covered by a specific capital change event. Given the context of French AMF filings, this is a standard monthly disclosure. I will classify it as RNS as it is a general regulatory announcement that doesn't fit the more specific capital change events like new issues or buybacks, but is a required disclosure.
2018-05-04 French
Generix Group - déclaration droits de vote au 31 3 2018
Declaration of Voting Results & Voting Rights Announcements Classification · 98% confidence The document is dated April 9, 2018, and its title explicitly mentions 'Information relative au nombre total de droits de vote et d'actions' (Information relative to the total number of voting rights and shares) as required by French commercial code (Article L. 233-8 II) and AMF regulation (Article 223-16). It provides a table showing the total number of shares and theoretical voting rights as of March 31, 2018. This content directly relates to the official disclosure of voting rights and share capital structure, which aligns best with the 'Declaration of Voting Results & Voting Rights Announcements' (DVA) category, as it is a formal declaration regarding voting rights.
2018-04-09 French

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.